栏目
Quality 4.0 technologies to enhance traditional Chinese medicine for overcoming healthcare challenges during COVID-19
Abid Haleem, Mohd Javaid, Ravi Pratap Singh, Rajiv Suman
2021, 4(2): 71-80. DOI: 10.1016/j.dcmed.2021.06.001
摘要 HTML全文 PDF
Analysis of the hotspots and trends in traditional Chinese medicine immunomodulation research based on bibliometrics
XIAO Li, MA Ning, LAI Han, YAN Junfeng, PENG Qinghua
2021, 4(2): 81-91. DOI: 10.1016/j.dcmed.2021.06.002
摘要 HTML全文 PDF
Research on classification diagnosis model of psoriasis based on deep residual
LI Peng, YI Na, DING Changsong, LI Sheng, MIN Hui
2021, 4(2): 92-101. DOI: 10.1016/j.dcmed.2021.06.003
摘要 HTML全文 PDF
Novel pyrimidine-benzimidazole hybrids with antibacterial and antifungal properties and potential inhibition of SARS-CoV-2 main protease and spike glycoprotein
Sharuk Khan, Mayura Kale, Falak Siddiqui, Nitin Nema
2021, 4(2): 102-119. DOI: 10.1016/j.dcmed.2021.06.004
摘要 HTML全文 PDF
Evaluation of Baishao (Radix Paeoniae Alba) and Chishao (Radix Paeoniae Rubra) from different origins based on characteristic spectra of amino acids
LI Shasha, ZHANG Yiping, DENG Yuanhui, WANG Qian, XIE Zhiru, Ibarra-Estrada Emmanuel, XIAO Xue
2021, 4(2): 120-129. DOI: 10.1016/j.dcmed.2021.06.005
摘要 HTML全文 PDF
Network pharmacology research and experimental verification of Huangqi (Astragalus Radix) and Jinyingzi (Rosae Laevigatae Fructus) in treating benign prostatic hyperplasia
ZHOU Huan, YANG Meng, YU Yipin, LIU Hui, QING Zhixing, CHEN Qihua
2021, 4(2): 130-143. DOI: 10.1016/j.dcmed.2021.06.006
摘要 HTML全文 PDF
Comparison of mechanisms and efficacies of five formulas for improving blood circulation and removing blood stasis
LI Jinxia, ZHOU Xiaoqing, ZHENG Caixing, LAI Lina, LI Ling
2021, 4(2): 144-158. DOI: 10.1016/j.dcmed.2021.06.007
摘要 HTML全文 PDF

E-mail Alerts